Question

The factors which affect the severity of anemia are the type of cancer, the nutritional status of the patient, the stage and extent of tumor burden, and bleeding. Recently published american society of clinical oncology/american society of hematology guidelines on the use of epoetin alfa (recombinant human erythropoietin [rhuepo]) in patients with chemotherapy-associated anemia [6] recommend treatment at a hemoglobin (hb) level <10 g/dl. For patients with less severe anemia (hb <12 g/dl but not <10 g/dl), treatment should be determined by an evaluation of the clinical manifestations of anemia

Answer 1

Answer:

Recently published american society of clinical oncology/american society of hematology guidelines on the use of epoetin alfa (recombinant human erythropoietin [rhuepo]) in patients with ..